Yantacaw Capital
Venture fund · from SEC filings

Ascent Biomedical Ventures I NY, L.P.

Abv · adviser of record: Abv, LLC · 2011 vintage

Ascent Biomedical Ventures I NY, L.P. is a 2011 venture fund managed by Abv. It reported $4.8mm in gross assets at year-end 2021, against a peak of $15.5mm in 2014.

Latest value held
$4.8mm year-end 2021
Peak
$15.5mm year-end 2014
Fund size
Not on file

Value held by year-end

$5mm$10mm$15mm$20mm20112012201320142015201620172018201920202021

Gross asset value reported on Form ADV at each year-end. Open in the Fund Tracker

Year-endGross assets÷ sizeChange
2021$4.8mm–+0%
2020$4.8mm–-69%
2019$15.5mm–+0%
2018$15.5mm–+0%
2017$15.5mm–+0%
2016$15.5mm–+0%
2015$15.5mm–+0%
2014$15.5mm–+19%
2013$13mm–+0%
2012$13mm–+2%
2011$12.7mm––

What public pensions report

InvestorAs ofCommitmentCash back (DPI)Total (TVPI)Still held
New York Common2008-03-31$15mm0.00x0.89x0.89x

Latest report from each pension, as multiples of paid-in capital. Where a pension reports only the value it holds, that value is shown in dollars under Still held. Linked dates go to the pension’s report.

Other funds from Abv

All Abv funds

About these numbers

Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-7959522259. Data updated October 13, 2026.

Is this your fund?

Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.